Molnupiravir Shows Limited Clinical Benefit in Mild to Moderate COVID-19, Despite Faster Early Viral Clearance
This comprehensive Cochrane review analyzed 11 randomized trials involving over 31,000 participants to evaluate the effectiveness of molnupiravir for confirmed ...
Read moreDetails